Sustained Relief of Neuropathic Pain by AAV-Targeted Expression of CBD3 Peptide in Rat Dorsal Root Ganglion

Scientists from the University of Wisconsin, Department of Anesthesiology, conclude that AAV-encoded CBD3 delivered to peripheral sensory neurons through DRG injection may be a valuable approach for exploring the role of presynaptic VGCCs and long-term modulation of neurotransmission, and may also be considered for development as a gene therapy strategy to treat chronic neuropathic pain.  READ MORE

Source: Gene Therapy

Send this to a friend